v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 11,168 $ 24,123
Accounts receivable, net 7,810 6,868
Inventory, net 18,331 19,064
Other current assets 5,731 4,615
Total current assets 43,040 54,670
Property and equipment, net 12,847 10,753
Capitalized software, net 4,897 4,525
Goodwill 5,833 5,833
Intangible assets, net 3,649 4,266
Intangible assets 3,649 4,266
Operating lease right-of-use assets 6,846 2,701
Deferred tax assets, net 24,515 24,793
Other non-current assets 72 72
Total assets 101,699 107,613
Current liabilities    
Accounts payable 6,576 6,826
Accrued expenses 14,321 9,806
Term loan, current 3,125 6,250
Deferred revenue, current 2,623 3,017
Earnout liabilities, current 2,750 0
Operating lease liabilities, current 705 592
Share repurchase liabilities 0 18,500
Total current liabilities 30,100 44,991
Term loan, net of current portion 118,377 95,782
Revolving loans 0 5,000
Deferred revenue, net of current portion 791 1,097
Operating lease liabilities, net of current portion 6,433 2,298
Other non-current liability 0 344
TRA liability 4,190 4,386
Earnout liabilities 0 4,112
Total liabilities 159,891 158,010
Commitments and contingencies (See Note 18)
Stockholders' Deficit    
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued or outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital 0 0
Accumulated deficit (50,941) (49,549)
Accumulated other comprehensive loss (25) (29)
Treasury stock, at cost (14,828) (8,965)
biote Corp.'s stockholders' deficit (65,790) (58,539)
Noncontrolling interest 7,598 8,142
Total stockholders' deficit (58,192) (50,397)
Total liabilities and stockholders' deficit 101,699 107,613
Class A Common Stock    
Stockholders' Deficit    
Common stock value 3 3
Class V Common Stock    
Stockholders' Deficit    
Common stock value $ 1 $ 1